How Much Weight Loss Can You Expect on 5mg Mounjaro?

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a dual GLP-1 and GIP receptor agonist that activates two distinct appetite and metabolic pathways in your brain and pancreas. The 5mg dose represents an intermediate step in most treatment protocols, and clinical evidence shows meaningful weight loss at this level. PlexusDx offers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with doses that may increase based on your individual response and tolerance—but your monthly price remains flat.

Tirzepatide 5mg Weight Loss: What Clinical Trials Show

The SURMOUNT clinical trial program evaluated tirzepatide across multiple dose levels in adults with overweight or obesity. Patients receiving tirzepatide showed cumulative weight reductions of 15–22% of baseline body weight by week 68, with results consistently outperforming older GLP-1 only medications. At the 5mg dose specifically, participants typically experienced weight loss of 10–15% of their starting weight, with responses varying based on genetics, diet adherence, and exercise patterns.

Weight loss on tirzepatide follows a dose-dependent pattern, meaning higher doses generally produce greater reductions, but the 5mg level delivers clinically meaningful results for many patients. Most individuals notice appetite suppression and reduced food cravings within the first two weeks, though visible weight changes on the scale usually appear between weeks 3–6. The dual-pathway mechanism of tirzepatide (targeting both GLP-1 and GIP receptors) distinguishes it from single-pathway competitors and contributes to its efficacy across diverse patient populations.

Timeline: When You'll See Weight Loss Results on 5mg

The first phase of tirzepatide treatment (weeks 1–2) focuses on tolerability and metabolic adjustment. During this period, you may experience decreased hunger and early appetite control, but scale weight typically remains stable. This phase is normal and reflects your body's initial response to the medication rather than a lack of progress.

Between weeks 3–8, most patients notice consistent weekly or biweekly weight loss, often at a rate of 0.5–1.5 pounds per week. This acceleration reflects sustained suppression of ghrelin (your hunger hormone) and improved insulin sensitivity from the GIP pathway activation. By week 8–12, cumulative loss often ranges from 5–10 pounds, signaling that the 5mg dose is producing measurable metabolic change. Individual timelines vary significantly based on your baseline metabolism, calorie intake, and genetic predisposition to GLP-1 sensitivity, which is why PlexusDx offers the Precision Peptide Genetic Test to identify your genetic response profile.

Factors That Influence Your Weight Loss on 5mg Tirzepatide

Your genetic makeup plays a major role in how your body responds to tirzepatide. Key genetic variants in the GLP1R gene (such as rs6923761) and GIPR gene (rs1800437) affect how strongly your receptor cells bind to the medication, determining whether you'll experience robust appetite suppression or a more gradual response. The Precision Peptide Genetic Test from PlexusDx maps 14 metabolic pathways and identifies 150+ genetic insights, revealing your individual sensitivity to GLP-1 and GIP activation before you commit to a treatment plan.

Lifestyle factors amplify tirzepatide's effects dramatically. Patients who combine the medication with consistent exercise, reduced processed food intake, and adequate sleep typically lose 20–30% more weight than those relying on medication alone. Hydration, meal timing, and protein intake also influence satiety and metabolic rate. Additionally, baseline body weight, age, and presence of type 2 diabetes affect the starting dose and expected weight loss curve—someone with a BMI of 35 may see faster initial results than someone with a BMI of 28, though both benefit from treatment.

PlexusDx Tirzepatide: Personalized Dosing Without Price Increases

PlexusDx delivers compounded tirzepatide injections from licensed 503A pharmacies at a flat $289/mo (or $249/mo on the 6-month plan), regardless of whether your dose increases from 2.5mg to 5mg to 7.5mg or beyond. This pricing model removes the financial barrier to dose optimization—your provider can adjust your dose based on your response and tolerance without fear of shocking price jumps. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorizations.

Each tirzepatide injection kit includes sterile supplies, dosing guidance, and access to PlexusDx clinical support. HSA and FSA accounts are eligible for purchase, reducing your out-of-pocket cost. For patients interested in understanding their genetic predisposition to GLP-1 and GIP pathway sensitivity, the Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, providing actionable insights into your peptide metabolism and pathway activation patterns.

Comparing 5mg Tirzepatide to Other GLP-1 Options

Tirzepatide differs fundamentally from traditional GLP-1 medications (like semaglutide) because it activates two independent receptor pathways. The GIP pathway adds additional metabolic benefits, including improved insulin secretion and reduced hepatic glucose production. Clinical evidence suggests tirzepatide produces 20–30% greater weight loss than GLP-1 monotherapy at equivalent timepoints, making the 5mg dose competitive with higher doses of single-pathway medications.

PlexusDx also offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan and a dual-compound GLP-Squared injection (combining semaglutide and tirzepatide) at $289/mo (or $249/mo on the 3-month plan) for patients seeking even greater synergy. For those preferring oral delivery, PlexusDx provides oral tirzepatide at $349/mo (or $279/mo on the 6-month plan) and oral semaglutide at $289/mo (or $249/mo on the 6-month plan). Your choice depends on your baseline weight, metabolic profile, and tolerance—all factors your PlexusDx provider will evaluate.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I expect to lose weight every week on 5mg tirzepatide?

Weight loss is not perfectly linear. Most patients lose consistently for 8–12 weeks, then may experience 1–2 week plateaus as their body adapts. This is normal and does not indicate treatment failure. Continuing the medication, increasing your dose if appropriate, or adjusting diet and exercise typically breaks plateaus.

What percentage of body weight do clinical trials show people lose on 5mg?

SURMOUNT trial data shows tirzepatide at 5mg produces approximately 10–15% body weight reduction over 68 weeks, though individual results range from 5–20% depending on genetics, adherence, and lifestyle. Results improve significantly when combined with structured nutrition and exercise.

How much does PlexusDx tirzepatide cost, and does the price change if my dose increases?

PlexusDx compounded tirzepatide injections cost $289 per month, flat. Whether you stay on 5mg or increase to 7.5mg or 10mg, your monthly price remains $289. This pricing structure ensures you can optimize your dose without financial penalty.

Are there side effects that slow weight loss on tirzepatide?

Nausea, constipation, and reduced appetite are common initially but typically resolve within 2–4 weeks as your body adjusts. These side effects do not slow weight loss—in fact, appetite suppression is the desired therapeutic effect. If side effects persist, your PlexusDx provider may recommend dose adjustment or a slower titration schedule.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The Precision Peptide Genetic Test analyzes key variants in GLP1R (rs6923761) and GIPR (rs1800437) genes, revealing your genetic sensitivity to tirzepatide's dual pathways. This $99 test provides personalized insights into your expected response, helping your provider optimize your dose and treatment plan from the start.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.